Adenosine  ||| S:0 E:10 ||| JJ
mapping  ||| S:10 E:18 ||| NN
for  ||| S:18 E:22 ||| IN
adenosine-dependent  ||| S:22 E:42 ||| JJ
accessory  ||| S:42 E:52 ||| NNS
pathway  ||| S:52 E:60 ||| VBP
ablation  ||| S:60 E:69 ||| VBG
This  ||| S:69 E:74 ||| DT
study  ||| S:74 E:80 ||| NN
describes  ||| S:80 E:90 ||| VBZ
the  ||| S:90 E:94 ||| DT
use  ||| S:94 E:98 ||| NN
of  ||| S:98 E:101 ||| IN
adenosine  ||| S:101 E:111 ||| NN
during  ||| S:111 E:118 ||| IN
ablation  ||| S:118 E:127 ||| JJ
procedures  ||| S:127 E:138 ||| NNS
to  ||| S:138 E:141 ||| TO
allow  ||| S:141 E:147 ||| VB
conduction  ||| S:147 E:158 ||| VBN
through  ||| S:158 E:166 ||| IN
adenosine-dependent  ||| S:166 E:186 ||| JJ
accessory  ||| S:186 E:196 ||| JJ
pathways  ||| S:196 E:205 ||| NNS
( ||| S:205 E:206 ||| -LRB-
APs ||| S:206 E:209 ||| NNP
) ||| S:209 E:210 ||| -RRB-
,  ||| S:210 E:212 ||| ,
which  ||| S:212 E:218 ||| WDT
are  ||| S:218 E:222 ||| VBP
inactive  ||| S:222 E:231 ||| VBN
at  ||| S:231 E:234 ||| IN
the  ||| S:234 E:238 ||| DT
time  ||| S:238 E:243 ||| NN
of  ||| S:243 E:246 ||| IN
the  ||| S:246 E:250 ||| DT
procedure ||| S:250 E:259 ||| NN
.  ||| S:259 E:261 ||| .
The  ||| S:261 E:265 ||| DT
technique  ||| S:265 E:275 ||| NN
allows  ||| S:275 E:282 ||| VBZ
for  ||| S:282 E:286 ||| IN
successful  ||| S:286 E:297 ||| JJ
mapping  ||| S:297 E:305 ||| NN
and  ||| S:305 E:309 ||| CC
ablation  ||| S:309 E:318 ||| NN
of  ||| S:318 E:321 ||| IN
these  ||| S:321 E:327 ||| DT
pathways ||| S:327 E:335 ||| NN
.  ||| S:335 E:337 ||| .
Retrospective  ||| S:337 E:351 ||| JJ
review  ||| S:351 E:358 ||| NN
of  ||| S:358 E:361 ||| IN
all  ||| S:361 E:365 ||| DT
patients  ||| S:365 E:374 ||| NNS
undergoing  ||| S:374 E:385 ||| VBG
AP  ||| S:385 E:388 ||| NNP
ablation  ||| S:388 E:397 ||| NN
from  ||| S:397 E:402 ||| IN
1998  ||| S:402 E:407 ||| CD
to  ||| S:407 E:410 ||| TO
2008  ||| S:410 E:415 ||| CD
to  ||| S:415 E:418 ||| TO
identify  ||| S:418 E:427 ||| VB
patients  ||| S:427 E:436 ||| NNS
with  ||| S:436 E:441 ||| IN
absent  ||| S:441 E:448 ||| JJ
or  ||| S:448 E:451 ||| CC
intermittent  ||| S:451 E:464 ||| JJ
AP  ||| S:464 E:467 ||| NNP
conduction  ||| S:467 E:478 ||| NN
during  ||| S:478 E:485 ||| IN
electrophysiology  ||| S:485 E:503 ||| JJ
study ||| S:503 E:508 ||| NN
.  ||| S:508 E:510 ||| .
Adenosine  ||| S:510 E:520 ||| JJ
boluses  ||| S:520 E:528 ||| NN
were  ||| S:528 E:533 ||| VBD
used  ||| S:533 E:538 ||| VBN
to  ||| S:538 E:541 ||| TO
activate  ||| S:541 E:550 ||| VB
the  ||| S:550 E:554 ||| DT
AP  ||| S:554 E:557 ||| NNP
for  ||| S:557 E:561 ||| IN
the  ||| S:561 E:565 ||| DT
purpose  ||| S:565 E:573 ||| NN
of  ||| S:573 E:576 ||| IN
mapping  ||| S:576 E:584 ||| NN
in  ||| S:584 E:587 ||| IN
each  ||| S:587 E:592 ||| DT
case ||| S:592 E:596 ||| NN
.  ||| S:596 E:598 ||| .
Adenosine  ||| S:598 E:608 ||| JJ
mapping  ||| S:608 E:616 ||| NN
was  ||| S:616 E:620 ||| VBD
utilized  ||| S:620 E:629 ||| VBN
in  ||| S:629 E:632 ||| IN
seven  ||| S:632 E:638 ||| CD
patients ||| S:638 E:646 ||| NNS
.  ||| S:646 E:648 ||| .
One  ||| S:648 E:652 ||| CD
patient  ||| S:652 E:660 ||| NN
had  ||| S:660 E:664 ||| VBD
a  ||| S:664 E:666 ||| DT
concealed  ||| S:666 E:676 ||| JJ
AP  ||| S:676 E:679 ||| NNP
at  ||| S:679 E:682 ||| IN
baseline  ||| S:682 E:691 ||| NN
and  ||| S:691 E:695 ||| CC
six  ||| S:695 E:699 ||| CD
patients  ||| S:699 E:708 ||| NNS
had  ||| S:708 E:712 ||| VBD
manifest  ||| S:712 E:721 ||| JJ
preexcitation  ||| S:721 E:735 ||| NN
at  ||| S:735 E:738 ||| IN
baseline  ||| S:738 E:747 ||| NN
but  ||| S:747 E:751 ||| CC
lost  ||| S:751 E:756 ||| VBD
AP  ||| S:756 E:759 ||| NNP
conduction  ||| S:759 E:770 ||| NN
during  ||| S:770 E:777 ||| IN
the  ||| S:777 E:781 ||| DT
case ||| S:781 E:785 ||| NN
.  ||| S:785 E:787 ||| .
Alternative  ||| S:787 E:799 ||| JJ
methods  ||| S:799 E:807 ||| NNS
of  ||| S:807 E:810 ||| IN
enhancing  ||| S:810 E:820 ||| VBG
AP  ||| S:820 E:823 ||| NNP
conduction  ||| S:823 E:834 ||| NN
were  ||| S:834 E:839 ||| VBD
attempted  ||| S:839 E:849 ||| VBN
in  ||| S:849 E:852 ||| IN
five  ||| S:852 E:857 ||| CD
patients ||| S:857 E:865 ||| NNS
,  ||| S:865 E:867 ||| ,
but  ||| S:867 E:871 ||| CC
failed ||| S:871 E:877 ||| VBD
.  ||| S:877 E:879 ||| .
Acute  ||| S:879 E:885 ||| JJ
ablation  ||| S:885 E:894 ||| JJ
results  ||| S:894 E:902 ||| NNS
included ||| S:902 E:910 ||| VBD
:  ||| S:910 E:912 ||| :
four  ||| S:912 E:917 ||| CD
patients  ||| S:917 E:926 ||| NNS
with  ||| S:926 E:931 ||| IN
complete  ||| S:931 E:940 ||| JJ
elimination  ||| S:940 E:952 ||| NN
of  ||| S:952 E:955 ||| IN
AP  ||| S:955 E:958 ||| NNP
conduction ||| S:958 E:968 ||| NN
,  ||| S:968 E:970 ||| ,
two  ||| S:970 E:974 ||| CD
patients  ||| S:974 E:983 ||| NNS
with  ||| S:983 E:988 ||| IN
AP  ||| S:988 E:991 ||| NNP
conduction  ||| S:991 E:1002 ||| VBD
only  ||| S:1002 E:1007 ||| RB
with  ||| S:1007 E:1012 ||| IN
adenosine ||| S:1012 E:1021 ||| NN
,  ||| S:1021 E:1023 ||| ,
and  ||| S:1023 E:1027 ||| CC
one  ||| S:1027 E:1031 ||| CD
patient  ||| S:1031 E:1039 ||| NN
with  ||| S:1039 E:1044 ||| IN
return  ||| S:1044 E:1051 ||| NN
of  ||| S:1051 E:1054 ||| IN
baseline  ||| S:1054 E:1063 ||| JJ
preexcitation ||| S:1063 E:1076 ||| NN
.  ||| S:1076 E:1078 ||| .
Patients  ||| S:1078 E:1087 ||| NNS
with  ||| S:1087 E:1092 ||| IN
residual  ||| S:1092 E:1101 ||| JJ
antegrade  ||| S:1101 E:1111 ||| JJ
conduction  ||| S:1111 E:1122 ||| NN
had  ||| S:1122 E:1126 ||| VBD
right  ||| S:1126 E:1132 ||| RB
superior  ||| S:1132 E:1141 ||| JJ
( ||| S:1141 E:1142 ||| -LRB-
anterior ||| S:1142 E:1150 ||| LS
)  ||| S:1150 E:1152 ||| -RRB-
septal  ||| S:1152 E:1159 ||| JJ
APs  ||| S:1159 E:1163 ||| NN
considered  ||| S:1163 E:1174 ||| VBN
too  ||| S:1174 E:1178 ||| RB
close  ||| S:1178 E:1184 ||| VB
to  ||| S:1184 E:1187 ||| TO
the  ||| S:1187 E:1191 ||| DT
atrioventricular  ||| S:1191 E:1208 ||| JJ
conduction  ||| S:1208 E:1219 ||| JJ
system  ||| S:1219 E:1226 ||| NN
for  ||| S:1226 E:1230 ||| IN
safe  ||| S:1230 E:1235 ||| JJ
ablation ||| S:1235 E:1243 ||| NN
.  ||| S:1243 E:1245 ||| .
At  ||| S:1245 E:1248 ||| IN
median  ||| S:1248 E:1255 ||| JJ
follow-up  ||| S:1255 E:1265 ||| NN
of  ||| S:1265 E:1268 ||| IN
2  ||| S:1268 E:1270 ||| CD
years ||| S:1270 E:1275 ||| NNS
,  ||| S:1275 E:1277 ||| ,
all  ||| S:1277 E:1281 ||| DT
three  ||| S:1281 E:1287 ||| CD
patients  ||| S:1287 E:1296 ||| NNS
with  ||| S:1296 E:1301 ||| IN
residual  ||| S:1301 E:1310 ||| JJ
AP  ||| S:1310 E:1313 ||| NNP
conduction  ||| S:1313 E:1324 ||| NN
had  ||| S:1324 E:1328 ||| VBD
recurrence  ||| S:1328 E:1339 ||| VBN
of  ||| S:1339 E:1342 ||| IN
supraventricular  ||| S:1342 E:1359 ||| JJ
tachycardia ||| S:1359 E:1370 ||| NN
;  ||| S:1370 E:1372 ||| :
the  ||| S:1372 E:1376 ||| DT
remainder  ||| S:1376 E:1386 ||| NN
remained  ||| S:1386 E:1395 ||| VBD
free  ||| S:1395 E:1400 ||| JJ
of  ||| S:1400 E:1403 ||| IN
preexcitation  ||| S:1403 E:1417 ||| NN
and  ||| S:1417 E:1421 ||| CC
SVT ||| S:1421 E:1424 ||| NNP
.  ||| S:1424 E:1426 ||| .
Adenosine  ||| S:1426 E:1436 ||| JJ
mapping  ||| S:1436 E:1444 ||| NN
is  ||| S:1444 E:1447 ||| VBZ
a  ||| S:1447 E:1449 ||| DT
useful  ||| S:1449 E:1456 ||| JJ
technique  ||| S:1456 E:1466 ||| NN
for  ||| S:1466 E:1470 ||| IN
facilitating  ||| S:1470 E:1483 ||| VBG
AP  ||| S:1483 E:1486 ||| NNP
ablation  ||| S:1486 E:1495 ||| NN
when  ||| S:1495 E:1500 ||| WRB
pathway  ||| S:1500 E:1508 ||| JJ
conduction  ||| S:1508 E:1519 ||| NN
is  ||| S:1519 E:1522 ||| VBZ
absent  ||| S:1522 E:1529 ||| JJ
or  ||| S:1529 E:1532 ||| CC
inconsistent ||| S:1532 E:1544 ||| JJ
,  ||| S:1544 E:1546 ||| ,
and  ||| S:1546 E:1550 ||| CC
may  ||| S:1550 E:1554 ||| MD
enhance  ||| S:1554 E:1562 ||| VB
conduction  ||| S:1562 E:1573 ||| VBN
in  ||| S:1573 E:1576 ||| IN
mechanically  ||| S:1576 E:1589 ||| JJ
inhibited  ||| S:1589 E:1599 ||| NN
or  ||| S:1599 E:1602 ||| CC
previously  ||| S:1602 E:1613 ||| RB
ablated  ||| S:1613 E:1621 ||| JJ
APs ||| S:1621 E:1624 ||| NN
.  ||| S:1624 E:1626 ||| .
Recurrence  ||| S:1626 E:1637 ||| NN
of  ||| S:1637 E:1640 ||| IN
AP  ||| S:1640 E:1643 ||| NNP
conduction  ||| S:1643 E:1654 ||| VBD
only  ||| S:1654 E:1659 ||| RB
during  ||| S:1659 E:1666 ||| IN
adenosine  ||| S:1666 E:1676 ||| JJ
administration  ||| S:1676 E:1691 ||| NN
is  ||| S:1691 E:1694 ||| VBZ
predictive  ||| S:1694 E:1705 ||| VBN
of  ||| S:1705 E:1708 ||| IN
late  ||| S:1708 E:1713 ||| JJ
recurrence ||| S:1713 E:1723 ||| NN
.  ||| S:1723 E:1725 ||| .
